Nkarta (NKTX) Other Gross PP&E Adjustments (2019 - 2026)

Nkarta's quarterly Other Gross PP&E Adjustments came in at $61.8 million in Q1 2026, up 2.63% year-on-year from $60.2 million in Q1 2025, and up 9.95% quarter-over-quarter from $56.2 million in Q4 2025.

Nkarta has reported Other Gross PP&E Adjustments for 8 years, with the latest figure at $61.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 2.63% year-over-year to $61.8 million; the trailing twelve-month figure through Mar 2026 stood at $61.8 million (up 2.63% YoY), and the FY2025 full-year result was $56.2 million, up 3.42% from the prior year.
  • Other Gross PP&E Adjustments for Q1 2026 stood at $61.8 million, up from $56.2 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $62.2 million in Q3 2025, with the low at -$62.0 million in Q1 2022.
  • Average Other Gross PP&E Adjustments over 5 years is $33.2 million, with a median of $53.1 million recorded in 2024.
  • Peak annual rise in Other Gross PP&E Adjustments reached 769.39% in 2022, while the deepest fall reached 17468.07% in 2022.
  • Tracing NKTX's Other Gross PP&E Adjustments over 5 years: stood at $18.4 million in 2022, then surged by 151.76% to $46.4 million in 2023, then grew by 17.17% to $54.4 million in 2024, then increased by 3.42% to $56.2 million in 2025, then rose by 9.95% to $61.8 million in 2026.
  • The last three Other Gross PP&E Adjustments figures came in at $61.8 million (Q1 2026), $56.2 million (Q4 2025), and $62.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -60,691.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -892,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -189.30 Mn
10 Nkarta 232.80 Mn 232.80 Mn - 61.82 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 61.82 Mn
Mar 31, 2026 61.82 Mn
Dec 31, 2025 56.23 Mn
Dec 31, 2025 56.23 Mn
Sep 30, 2025 62.17 Mn
Sep 30, 2025 62.17 Mn
Jun 30, 2025 60.74 Mn
Jun 30, 2025 60.74 Mn
Mar 31, 2025 60.24 Mn
Mar 31, 2025 60.24 Mn
Dec 31, 2024 54.37 Mn
Dec 31, 2024 54.37 Mn
Sep 30, 2024 55.98 Mn
Sep 30, 2024 55.98 Mn
Jun 30, 2024 54.39 Mn
Jun 30, 2024 54.39 Mn
Mar 31, 2024 53.11 Mn
Mar 31, 2024 53.11 Mn
Dec 31, 2023 46.40 Mn
Dec 31, 2023 46.40 Mn
Sep 30, 2023 46.61 Mn
Sep 30, 2023 46.61 Mn
Jun 30, 2023 42.48 Mn
Jun 30, 2023 42.48 Mn
Mar 31, 2023 30.82 Mn
Mar 31, 2023 30.82 Mn
Dec 31, 2022 18.43 Mn
Dec 31, 2022 18.43 Mn
Sep 30, 2022 -32.63 Mn
Sep 30, 2022 -32.63 Mn
Jun 30, 2022 -44.66 Mn
Jun 30, 2022 -44.66 Mn
Mar 31, 2022 -62.00 Mn
Mar 31, 2022 -62.00 Mn
Dec 31, 2021 2.12 Mn
Dec 31, 2021 2.12 Mn
Sep 30, 2021 5.78 Mn
Sep 30, 2021 5.78 Mn
Jun 30, 2021 1.40 Mn
Jun 30, 2021 1.40 Mn
Mar 31, 2021 357,000.00
Mar 31, 2021 357,000.00
Dec 31, 2020 1.40 Mn
Dec 31, 2020 1.40 Mn
Sep 30, 2020 1.57 Mn
Sep 30, 2020 1.57 Mn
Jun 30, 2020 -339,259.00
Jun 30, 2020 -339,259.00
Dec 31, 2019 -3.42 Mn
Dec 31, 2019 -3.42 Mn